Haemonetics Corporation (HAE) Financials
Key financial figures for Haemonetics Corporation (Q1 2027).
Haemonetics reported revenue of $339.4 million for Q1 FY2027, up 5.6% from the same period a year earlier. Net income was $33.0 million, or $0.72 per share. Operating margin came to 16.93%, against 16.76% a year earlier. Free cash flow for the period was $44.4 million. Across the last 5 reported quarters, quarterly revenue has risen from $321.4 million in Q1 FY2026 to $339.4 million in Q1 FY2027. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Haemonetics are on the SentiSense financials page.
- Revenue
- $339M
- Net Income
- $33M
- EPS
- $0.73
- Total Assets
- $2.4B
- Operating Cash Flow
- $52M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q1 FY2027 | $339M | $33M | $0.72 | 16.93% | $44M |
| Q4 FY2026 | $346M | -$20M | -$0.44 | 14.85% | $53M |
| Q3 FY2026 | $339M | $45M | $0.95 | 20.52% | $87M |
| Q2 FY2026 | $327M | $39M | $0.81 | 20.55% | $106M |
| Q1 FY2026 | $321M | $34M | $0.70 | 16.76% | $14M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2026 | $1.3B | $97M | $2.05 | 18.1% | $260M |
| FY2025 | $1.4B | $168M | $3.31 | 16.3% | $142M |
| FY2024 | $1.3B | $118M | $2.29 | 12.6% | $144M |
Frequently asked questions
What was Haemonetics's revenue last quarter?
Haemonetics reported revenue of $339.4 million for Q1 FY2027, up 5.6% from the same period a year earlier.
Is Haemonetics profitable?
Yes. Haemonetics reported net income of $33.0 million for Q1 FY2027, a net margin of 9.73% on revenue.
How has Haemonetics's margin trended?
Operating margin was 16.93% in Q1 FY2027, compared with 16.76% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Haemonetics generate?
Haemonetics generated free cash flow of $44.4 million in Q1 FY2027, after capital expenditure.
Full income statement, balance sheet and cash flow for Haemonetics Corporation on SentiSense, with up to forty quarters and twenty fiscal years of history.